LayerRx Mapping ID
318
Slot System
Featured Buckets
Featured Buckets Admin
Medscape Lead Concept
3029493

DHEA supplementation: The claims in perspective

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
DHEA supplementation: The claims in perspective
Article PDF
Author and Disclosure Information

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Issue
Cleveland Clinic Journal of Medicine - 72(11)
Publications
Topics
Page Number
965-966, 968, 970-971, 975-977, 983-984
Sections
Author and Disclosure Information

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Author and Disclosure Information

Ewa Olech, MD
Clinical Pharmacology Research Program,Oklahoma Medical Research Foundation; Clinical Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City

Joan T. Merrill, MD
Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and Professor of Medicine, Oklahoma Health Sciences Center, Oklahoma City; Medical Director, Lupus Foundation of America

Address: Joan T. Merrill, MD, Oklahoma Medical Research Foundation, 825 Northeast 13th Street, Oklahoma City, OK 73104

Dr. Merrill has indicated that she is a consultant for Genelabs and has received grant or research support from Genelabs.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Issue
Cleveland Clinic Journal of Medicine - 72(11)
Page Number
965-966, 968, 970-971, 975-977, 983-984
Page Number
965-966, 968, 970-971, 975-977, 983-984
Publications
Publications
Topics
Article Type
Display Headline
DHEA supplementation: The claims in perspective
Display Headline
DHEA supplementation: The claims in perspective
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Advice for when you begin exercising

Article Type
Changed
Mon, 09/10/2018 - 15:48
Display Headline
Advice for when you begin exercising
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(8)
Publications
Topics
Page Number
657
Sections
Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 72(8)
Issue
Cleveland Clinic Journal of Medicine - 72(8)
Page Number
657
Page Number
657
Publications
Publications
Topics
Article Type
Display Headline
Advice for when you begin exercising
Display Headline
Advice for when you begin exercising
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Genetics and cardiomyopathy: Where are we now?

Article Type
Changed
Mon, 09/10/2018 - 11:14
Display Headline
Genetics and cardiomyopathy: Where are we now?
Article PDF
Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.
Issue
Cleveland Clinic Journal of Medicine - 72(6)
Publications
Topics
Page Number
465-466, 469-470, 472-473, 477-480, 482-483
Sections
Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.
Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.
Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(6)
Issue
Cleveland Clinic Journal of Medicine - 72(6)
Page Number
465-466, 469-470, 472-473, 477-480, 482-483
Page Number
465-466, 469-470, 472-473, 477-480, 482-483
Publications
Publications
Topics
Article Type
Display Headline
Genetics and cardiomyopathy: Where are we now?
Display Headline
Genetics and cardiomyopathy: Where are we now?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies

Article Type
Changed
Mon, 09/24/2018 - 15:25
Display Headline
Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies
Article PDF
Author and Disclosure Information

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kavurum@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 71(2)
Publications
Topics
Page Number
88, 90, 92, 95-98, 100-101, 104-106
Sections
Author and Disclosure Information

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kavurum@ccf.org

Author and Disclosure Information

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kavurum@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(2)
Issue
Cleveland Clinic Journal of Medicine - 71(2)
Page Number
88, 90, 92, 95-98, 100-101, 104-106
Page Number
88, 90, 92, 95-98, 100-101, 104-106
Publications
Publications
Topics
Article Type
Display Headline
Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies
Display Headline
Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Insurance, risk, and genomics

Article Type
Changed
Mon, 09/24/2018 - 14:11
Display Headline
Insurance, risk, and genomics
Article PDF
Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Issue
Cleveland Clinic Journal of Medicine - 71(1)
Publications
Topics
Page Number
6
Sections
Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(1)
Issue
Cleveland Clinic Journal of Medicine - 71(1)
Page Number
6
Page Number
6
Publications
Publications
Topics
Article Type
Display Headline
Insurance, risk, and genomics
Display Headline
Insurance, risk, and genomics
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Genetic testing and health insurance: Can they coexist?

Article Type
Changed
Mon, 09/24/2018 - 14:16
Display Headline
Genetic testing and health insurance: Can they coexist?
Article PDF
Author and Disclosure Information

Nancy L. Fisher, MD
Clinical Associate Professor, University of Washington; Member, Planning and Evaluation Committee for Ethical, Legal, and Social Implications, Human Genome Project

Issue
Cleveland Clinic Journal of Medicine - 71(1)
Publications
Topics
Page Number
8-9
Sections
Author and Disclosure Information

Nancy L. Fisher, MD
Clinical Associate Professor, University of Washington; Member, Planning and Evaluation Committee for Ethical, Legal, and Social Implications, Human Genome Project

Author and Disclosure Information

Nancy L. Fisher, MD
Clinical Associate Professor, University of Washington; Member, Planning and Evaluation Committee for Ethical, Legal, and Social Implications, Human Genome Project

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(1)
Issue
Cleveland Clinic Journal of Medicine - 71(1)
Page Number
8-9
Page Number
8-9
Publications
Publications
Topics
Article Type
Display Headline
Genetic testing and health insurance: Can they coexist?
Display Headline
Genetic testing and health insurance: Can they coexist?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Genetic discrimination arising from cancer risk assessments: A societal dilemma

Article Type
Changed
Mon, 09/24/2018 - 14:19
Display Headline
Genetic discrimination arising from cancer risk assessments: A societal dilemma
Article PDF
Author and Disclosure Information

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology and the Taussig Cancer Center, The Cleveland Clinic

Address: Maurie Markman, MD, Chairman, Taussig Cancer Center, Department of Hematology/Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail markmam@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 71(1)
Publications
Topics
Page Number
12, 15-18
Legacy Keywords
Genetics and Reproduction
Sections
Author and Disclosure Information

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology and the Taussig Cancer Center, The Cleveland Clinic

Address: Maurie Markman, MD, Chairman, Taussig Cancer Center, Department of Hematology/Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail markmam@ccf.org

Author and Disclosure Information

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology and the Taussig Cancer Center, The Cleveland Clinic

Address: Maurie Markman, MD, Chairman, Taussig Cancer Center, Department of Hematology/Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail markmam@ccf.org

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(1)
Issue
Cleveland Clinic Journal of Medicine - 71(1)
Page Number
12, 15-18
Page Number
12, 15-18
Publications
Publications
Topics
Article Type
Display Headline
Genetic discrimination arising from cancer risk assessments: A societal dilemma
Display Headline
Genetic discrimination arising from cancer risk assessments: A societal dilemma
Legacy Keywords
Genetics and Reproduction
Legacy Keywords
Genetics and Reproduction
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Chemoprevention of colorectal cancer: Slow, steady progress

Article Type
Changed
Mon, 11/05/2018 - 08:02
Display Headline
Chemoprevention of colorectal cancer: Slow, steady progress
Article PDF
Author and Disclosure Information

Carol A. Burke, MD
Department of Gastroenterology, The Cleveland Clinic

William M. Bauer, MD
Glen Falls Hospital, Glen Falls, New York

Bret Lashner, MD
Department of Gastroenterology, The Cleveland Clinic

Address: Carol A. Burke, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; email: burkec1@ccf.org

Dr. Burke has indicated that she has received grant or research support from Merck and Co.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 70(4)
Publications
Topics
Page Number
346-350
Sections
Author and Disclosure Information

Carol A. Burke, MD
Department of Gastroenterology, The Cleveland Clinic

William M. Bauer, MD
Glen Falls Hospital, Glen Falls, New York

Bret Lashner, MD
Department of Gastroenterology, The Cleveland Clinic

Address: Carol A. Burke, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; email: burkec1@ccf.org

Dr. Burke has indicated that she has received grant or research support from Merck and Co.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Carol A. Burke, MD
Department of Gastroenterology, The Cleveland Clinic

William M. Bauer, MD
Glen Falls Hospital, Glen Falls, New York

Bret Lashner, MD
Department of Gastroenterology, The Cleveland Clinic

Address: Carol A. Burke, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; email: burkec1@ccf.org

Dr. Burke has indicated that she has received grant or research support from Merck and Co.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(4)
Issue
Cleveland Clinic Journal of Medicine - 70(4)
Page Number
346-350
Page Number
346-350
Publications
Publications
Topics
Article Type
Display Headline
Chemoprevention of colorectal cancer: Slow, steady progress
Display Headline
Chemoprevention of colorectal cancer: Slow, steady progress
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes

Article Type
Changed
Mon, 12/17/2018 - 08:12
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Article PDF
Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
928-929, 933, 936, 939, 943-946
Sections
Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
928-929, 933, 936, 939, 943-946
Page Number
928-929, 933, 936, 939, 943-946
Publications
Publications
Topics
Article Type
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Hereditary hemochromatosis: A common, often unrecognized, genetic disease

Article Type
Changed
Tue, 12/18/2018 - 12:03
Display Headline
Hereditary hemochromatosis: A common, often unrecognized, genetic disease
Article PDF
Author and Disclosure Information

Geraldine M. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital; and  Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

Conor J. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Dermot Kenny, MD
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

John Crowe, MD, PhD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Stephen Eustace, MB
Department of Radiology, University College and Mater Misericordiae Hospital, Dublin

Address: Geraldine M. McCarthy, MD, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123, St. Stephen’s Green, Dublin 2, Ireland; e-mail: gmccarthy@rcsi.ie

Issue
Cleveland Clinic Journal of Medicine - 69(3)
Publications
Topics
Page Number
224-226, 229-230, 232-233, 236-237
Sections
Author and Disclosure Information

Geraldine M. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital; and  Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

Conor J. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Dermot Kenny, MD
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

John Crowe, MD, PhD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Stephen Eustace, MB
Department of Radiology, University College and Mater Misericordiae Hospital, Dublin

Address: Geraldine M. McCarthy, MD, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123, St. Stephen’s Green, Dublin 2, Ireland; e-mail: gmccarthy@rcsi.ie

Author and Disclosure Information

Geraldine M. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital; and  Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

Conor J. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Dermot Kenny, MD
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

John Crowe, MD, PhD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Stephen Eustace, MB
Department of Radiology, University College and Mater Misericordiae Hospital, Dublin

Address: Geraldine M. McCarthy, MD, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123, St. Stephen’s Green, Dublin 2, Ireland; e-mail: gmccarthy@rcsi.ie

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 69(3)
Issue
Cleveland Clinic Journal of Medicine - 69(3)
Page Number
224-226, 229-230, 232-233, 236-237
Page Number
224-226, 229-230, 232-233, 236-237
Publications
Publications
Topics
Article Type
Display Headline
Hereditary hemochromatosis: A common, often unrecognized, genetic disease
Display Headline
Hereditary hemochromatosis: A common, often unrecognized, genetic disease
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media